Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dextromethorphan pharmacogenetics

Jacqz-Aigrain E, Funck-Brentano C, Crested T. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. Pharmacogenetics 1993 3 197-204. [Pg.624]

Kiipfer A, Schmid B, Pfaff G. Pharmacogenetics of dextromethorphan O-demethylation in man. Xenobiotica 1986 16 4214-33. [Pg.635]

Evans WE, Relling MV. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers. Pharmacogenetics 1991 1 143-148. [Pg.636]

Kashuba AD, Nafziger AN, Kearns GL, Leeder JS, Gotschall R, Gaedigk A, Bertino JS Jr. 1999. Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity. Pharmacogenetics 9 453-62... [Pg.30]

Kashuba AD, Nafeiger AN, Kearns GL, Leeder JS, Shirey CS, Gotschall R, et al. Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping. Pharmacogenetics 1998 8 403-10. [Pg.1613]

See other pages where Dextromethorphan pharmacogenetics is mentioned: [Pg.76]    [Pg.191]    [Pg.192]    [Pg.15]    [Pg.61]   
See also in sourсe #XX -- [ Pg.61 ]



SEARCH



Dextromethorphan

Pharmacogenetic

Pharmacogenetics

© 2024 chempedia.info